Report Detail
COVID-19 Impact on Global Medical Hemostatic Agents, Market Insights and Forecast to 2026
- RnM4080445 |
- 26 June, 2020 |
- Global |
- 153 Pages |
- QYResearch |
- Pharma & Healthcare
Medical Hemostatic Agents market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Medical Hemostatic Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Medical Hemostatic Agents market is segmented into
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Segment by Application, the Medical Hemostatic Agents market is segmented into
Hospitals
Surgical Centers
Clnics
Others
Regional and Country-level Analysis
The Medical Hemostatic Agents market is analysed and market size information is provided by regions (countries).
The key regions covered in the Medical Hemostatic Agents market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Medical Hemostatic Agents Market Share Analysis
Medical Hemostatic Agents market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Medical Hemostatic Agents business, the date to enter into the Medical Hemostatic Agents market, Medical Hemostatic Agents product introduction, recent developments, etc.
The major vendors covered:
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom’Up SAS
1 Study Coverage
- 1.1 Medical Hemostatic Agents Product Introduction
- 1.2 Market Segments
- 1.3 Key Medical Hemostatic Agents Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Medical Hemostatic Agents Market Size Growth Rate by Type
- 1.4.2 Gelation Sponge
- 1.4.3 Oxidized Regenerated Cellulose Based Hemostats
- 1.4.4 Others
- 1.5 Market by Application
- 1.5.1 Global Medical Hemostatic Agents Market Size Growth Rate by Application
- 1.5.2 Hospitals
- 1.5.3 Surgical Centers
- 1.5.4 Clnics
- 1.5.5 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Medical Hemostatic Agents Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Medical Hemostatic Agents Industry
- 1.6.1.1 Medical Hemostatic Agents Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Medical Hemostatic Agents Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Medical Hemostatic Agents Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Medical Hemostatic Agents Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Medical Hemostatic Agents Market Size Estimates and Forecasts
- 2.1.1 Global Medical Hemostatic Agents Revenue 2015-2026
- 2.1.2 Global Medical Hemostatic Agents Sales 2015-2026
- 2.2 Medical Hemostatic Agents Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Medical Hemostatic Agents Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Medical Hemostatic Agents Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Medical Hemostatic Agents Competitor Landscape by Players
- 3.1 Medical Hemostatic Agents Sales by Manufacturers
- 3.1.1 Medical Hemostatic Agents Sales by Manufacturers (2015-2020)
- 3.1.2 Medical Hemostatic Agents Sales Market Share by Manufacturers (2015-2020)
- 3.2 Medical Hemostatic Agents Revenue by Manufacturers
- 3.2.1 Medical Hemostatic Agents Revenue by Manufacturers (2015-2020)
- 3.2.2 Medical Hemostatic Agents Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Medical Hemostatic Agents Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Medical Hemostatic Agents Revenue in 2019
- 3.2.5 Global Medical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Medical Hemostatic Agents Price by Manufacturers
- 3.4 Medical Hemostatic Agents Manufacturing Base Distribution, Product Types
- 3.4.1 Medical Hemostatic Agents Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Medical Hemostatic Agents Product Type
- 3.4.3 Date of International Manufacturers Enter into Medical Hemostatic Agents Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Medical Hemostatic Agents Market Size by Type (2015-2020)
- 4.1.1 Global Medical Hemostatic Agents Sales by Type (2015-2020)
- 4.1.2 Global Medical Hemostatic Agents Revenue by Type (2015-2020)
- 4.1.3 Medical Hemostatic Agents Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Medical Hemostatic Agents Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Medical Hemostatic Agents Sales Forecast by Type (2021-2026)
- 4.2.2 Global Medical Hemostatic Agents Revenue Forecast by Type (2021-2026)
- 4.2.3 Medical Hemostatic Agents Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Medical Hemostatic Agents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Medical Hemostatic Agents Market Size by Application (2015-2020)
- 5.1.1 Global Medical Hemostatic Agents Sales by Application (2015-2020)
- 5.1.2 Global Medical Hemostatic Agents Revenue by Application (2015-2020)
- 5.1.3 Medical Hemostatic Agents Price by Application (2015-2020)
- 5.2 Medical Hemostatic Agents Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Medical Hemostatic Agents Sales Forecast by Application (2021-2026)
- 5.2.2 Global Medical Hemostatic Agents Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Medical Hemostatic Agents Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Medical Hemostatic Agents by Country
- 6.1.1 North America Medical Hemostatic Agents Sales by Country
- 6.1.2 North America Medical Hemostatic Agents Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Medical Hemostatic Agents Market Facts & Figures by Type
- 6.3 North America Medical Hemostatic Agents Market Facts & Figures by Application
7 Europe
- 7.1 Europe Medical Hemostatic Agents by Country
- 7.1.1 Europe Medical Hemostatic Agents Sales by Country
- 7.1.2 Europe Medical Hemostatic Agents Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Medical Hemostatic Agents Market Facts & Figures by Type
- 7.3 Europe Medical Hemostatic Agents Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Medical Hemostatic Agents by Region
- 8.1.1 Asia Pacific Medical Hemostatic Agents Sales by Region
- 8.1.2 Asia Pacific Medical Hemostatic Agents Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Medical Hemostatic Agents Market Facts & Figures by Type
- 8.3 Asia Pacific Medical Hemostatic Agents Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Medical Hemostatic Agents by Country
- 9.1.1 Latin America Medical Hemostatic Agents Sales by Country
- 9.1.2 Latin America Medical Hemostatic Agents Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Medical Hemostatic Agents Market Facts & Figures by Type
- 9.3 Central & South America Medical Hemostatic Agents Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Medical Hemostatic Agents by Country
- 10.1.1 Middle East and Africa Medical Hemostatic Agents Sales by Country
- 10.1.2 Middle East and Africa Medical Hemostatic Agents Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Medical Hemostatic Agents Market Facts & Figures by Type
- 10.3 Middle East and Africa Medical Hemostatic Agents Market Facts & Figures by Application
11 Company Profiles
- 11.1 Ethicon
- 11.1.1 Ethicon Corporation Information
- 11.1.2 Ethicon Description, Business Overview and Total Revenue
- 11.1.3 Ethicon Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Ethicon Medical Hemostatic Agents Products Offered
- 11.1.5 Ethicon Recent Development
- 11.2 Pfizer
- 11.2.1 Pfizer Corporation Information
- 11.2.2 Pfizer Description, Business Overview and Total Revenue
- 11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Pfizer Medical Hemostatic Agents Products Offered
- 11.2.5 Pfizer Recent Development
- 11.3 Baxter International
- 11.3.1 Baxter International Corporation Information
- 11.3.2 Baxter International Description, Business Overview and Total Revenue
- 11.3.3 Baxter International Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Baxter International Medical Hemostatic Agents Products Offered
- 11.3.5 Baxter International Recent Development
- 11.4 C. R. Bard
- 11.4.1 C. R. Bard Corporation Information
- 11.4.2 C. R. Bard Description, Business Overview and Total Revenue
- 11.4.3 C. R. Bard Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 C. R. Bard Medical Hemostatic Agents Products Offered
- 11.4.5 C. R. Bard Recent Development
- 11.5 The Medicines Company
- 11.5.1 The Medicines Company Corporation Information
- 11.5.2 The Medicines Company Description, Business Overview and Total Revenue
- 11.5.3 The Medicines Company Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 The Medicines Company Medical Hemostatic Agents Products Offered
- 11.5.5 The Medicines Company Recent Development
- 11.6 Anika Therapeutics
- 11.6.1 Anika Therapeutics Corporation Information
- 11.6.2 Anika Therapeutics Description, Business Overview and Total Revenue
- 11.6.3 Anika Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Anika Therapeutics Medical Hemostatic Agents Products Offered
- 11.6.5 Anika Therapeutics Recent Development
- 11.7 Advanced Medical Solutions
- 11.7.1 Advanced Medical Solutions Corporation Information
- 11.7.2 Advanced Medical Solutions Description, Business Overview and Total Revenue
- 11.7.3 Advanced Medical Solutions Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Advanced Medical Solutions Medical Hemostatic Agents Products Offered
- 11.7.5 Advanced Medical Solutions Recent Development
- 11.8 Integra LifeSciences
- 11.8.1 Integra LifeSciences Corporation Information
- 11.8.2 Integra LifeSciences Description, Business Overview and Total Revenue
- 11.8.3 Integra LifeSciences Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Integra LifeSciences Medical Hemostatic Agents Products Offered
- 11.8.5 Integra LifeSciences Recent Development
- 11.9 B Braun Melsungen
- 11.9.1 B Braun Melsungen Corporation Information
- 11.9.2 B Braun Melsungen Description, Business Overview and Total Revenue
- 11.9.3 B Braun Melsungen Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 B Braun Melsungen Medical Hemostatic Agents Products Offered
- 11.9.5 B Braun Melsungen Recent Development
- 11.10 Gelita Medical
- 11.10.1 Gelita Medical Corporation Information
- 11.10.2 Gelita Medical Description, Business Overview and Total Revenue
- 11.10.3 Gelita Medical Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Gelita Medical Medical Hemostatic Agents Products Offered
- 11.10.5 Gelita Medical Recent Development
- 11.1 Ethicon
- 11.1.1 Ethicon Corporation Information
- 11.1.2 Ethicon Description, Business Overview and Total Revenue
- 11.1.3 Ethicon Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Ethicon Medical Hemostatic Agents Products Offered
- 11.1.5 Ethicon Recent Development
- 11.12 Vascular Solutions
- 11.12.1 Vascular Solutions Corporation Information
- 11.12.2 Vascular Solutions Description, Business Overview and Total Revenue
- 11.12.3 Vascular Solutions Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Vascular Solutions Products Offered
- 11.12.5 Vascular Solutions Recent Development
- 11.13 Marine Polymer Technologies
- 11.13.1 Marine Polymer Technologies Corporation Information
- 11.13.2 Marine Polymer Technologies Description, Business Overview and Total Revenue
- 11.13.3 Marine Polymer Technologies Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Marine Polymer Technologies Products Offered
- 11.13.5 Marine Polymer Technologies Recent Development
- 11.14 Z-Medica
- 11.14.1 Z-Medica Corporation Information
- 11.14.2 Z-Medica Description, Business Overview and Total Revenue
- 11.14.3 Z-Medica Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Z-Medica Products Offered
- 11.14.5 Z-Medica Recent Development
- 11.15 CryoLife
- 11.15.1 CryoLife Corporation Information
- 11.15.2 CryoLife Description, Business Overview and Total Revenue
- 11.15.3 CryoLife Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 CryoLife Products Offered
- 11.15.5 CryoLife Recent Development
- 11.16 BioCer Entwicklungs
- 11.16.1 BioCer Entwicklungs Corporation Information
- 11.16.2 BioCer Entwicklungs Description, Business Overview and Total Revenue
- 11.16.3 BioCer Entwicklungs Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 BioCer Entwicklungs Products Offered
- 11.16.5 BioCer Entwicklungs Recent Development
- 11.17 Biom’Up SAS
- 11.17.1 Biom’Up SAS Corporation Information
- 11.17.2 Biom’Up SAS Description, Business Overview and Total Revenue
- 11.17.3 Biom’Up SAS Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 Biom’Up SAS Products Offered
- 11.17.5 Biom’Up SAS Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Medical Hemostatic Agents Market Estimates and Projections by Region
- 12.1.1 Global Medical Hemostatic Agents Sales Forecast by Regions 2021-2026
- 12.1.2 Global Medical Hemostatic Agents Revenue Forecast by Regions 2021-2026
- 12.2 North America Medical Hemostatic Agents Market Size Forecast (2021-2026)
- 12.2.1 North America: Medical Hemostatic Agents Sales Forecast (2021-2026)
- 12.2.2 North America: Medical Hemostatic Agents Revenue Forecast (2021-2026)
- 12.2.3 North America: Medical Hemostatic Agents Market Size Forecast by Country (2021-2026)
- 12.3 Europe Medical Hemostatic Agents Market Size Forecast (2021-2026)
- 12.3.1 Europe: Medical Hemostatic Agents Sales Forecast (2021-2026)
- 12.3.2 Europe: Medical Hemostatic Agents Revenue Forecast (2021-2026)
- 12.3.3 Europe: Medical Hemostatic Agents Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Medical Hemostatic Agents Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Medical Hemostatic Agents Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Medical Hemostatic Agents Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Medical Hemostatic Agents Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Medical Hemostatic Agents Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Medical Hemostatic Agents Sales Forecast (2021-2026)
- 12.5.2 Latin America: Medical Hemostatic Agents Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Medical Hemostatic Agents Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Medical Hemostatic Agents Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Medical Hemostatic Agents Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Medical Hemostatic Agents Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Medical Hemostatic Agents Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Medical Hemostatic Agents Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Medical Hemostatic Agents Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Medical Hemostatic Agents. Industry analysis & Market Report on COVID-19 Impact on Global Medical Hemostatic Agents is a syndicated market report, published as COVID-19 Impact on Global Medical Hemostatic Agents, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Medical Hemostatic Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
